Clinical trial

Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in…

NCT00193739 · Tata Memorial Hospital, Other · Unknown status

Key facts

NCT number NCT00193739
Title Neoadjuvant Chemotherapy Followed by Surgery Versus Concurrent Chemoradiation in Carcinoma of the Cervix
Official title A Prospective Randomized Trial of Neoadjuvant Chemotherapy and Surgery Versus Concurrent Chemoradiation Therapy in Patients With Stage IB2-IIB Squamous Carcinoma of the Uterine Cervix
Acronym NACTcervix
Lead sponsor Tata Memorial Hospital, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Cancer of Cervix
Intervention type Drug, Procedure, Radiation
Interventions NACT, Radical abdominal hysterectomy (class III), BPLND & lower para aortic lymph node sampling, Inj.Cisplatin, Concurrent chemo radiotherapy
Enrollment 635
Start date Sep 4, 2003
Primary completion Jul 31, 2020
Completion Jul 31, 2020
First posted Sep 19, 2005
Last update posted Sep 20, 2019
Countries India

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies